Latest 20-F annual reports

NYSE
Nomad Foods Limited reports a decrease in 2025 revenue and profit, alongside persistent material weaknesses in internal controls and a significant debt refinancing.
NASDAQ
TORM plc experienced a substantial decrease in net profit and TCE earnings in 2025, driven by challenging market conditions despite strategic fleet acquisitions and strong liquidity management.
NYSE
Amer Sports, Inc. announced robust financial results for the fiscal year ended December 31, 2025, with significant revenue and net income growth driven by DTC expansion and strong performance across all segments.
NASDAQ
NOVONIX Limited reports a net loss of $92.7 million for 2025, secures $100 million in convertible debentures, and strategically divests its Battery Technology Solutions business to focus on North American synthetic graphite production.
NASDAQ
Ferrovial SE announced a 5.2% revenue increase to €9,627 million in 2025, driven by robust performance in its Highways and Construction divisions, alongside strategic asset rotations and a remediated internal control weakness.
NASDAQ
PolyPid Ltd. reported positive topline results from its pivotal SHIELD II Phase 3 trial for D-PLEX100, showing significant reduction in surgical site infections, and plans for a rolling NDA submission by Q1 2026.
NYSE
Valens Semiconductor reports a 22.1% revenue increase in 2025 driven by Cross-Industry recovery, alongside strategic acquisitions and new product developments, despite a decline in Automotive segment revenue.
NASDAQ
ASML Holding NV delivered robust financial results in 2025, fueled by surging AI demand and significant progress in its EUV lithography technology, while outlining ambitious long-term growth and sustainability targets.
NASDAQ
Icon Energy Corp. saw a significant revenue increase in 2025 driven by fleet expansion, but reported a net loss due to higher operating costs and equity-linked instrument losses.
NYSE
Alcon reported a 5% increase in net sales to $10.3 billion in 2025, but saw a 4% decline in operating income and net income, alongside significant product launches and strategic acquisitions.
AMEX
Regentis Biomaterials reported a significant net loss in 2025, driven by increased administrative costs and financial expenses, while advancing its pivotal GelrinC clinical trial and securing IPO funding.
NYSE
AstraZeneca appoints KPMG as its external auditor, replacing PricewaterhouseCoopers after a competitive tender process.
NASDAQ
Jiuzi Holdings Inc. reported a significant reduction in net loss for fiscal year 2025, driven by lower impairment and share-based compensation, alongside a strategic pivot to new energy battery sales and future EV production in Southeast Asia.
Brightstar Lottery PLC reports a net loss from continuing operations in 2025, influenced by a major Italian Lotto license payment and significant foreign exchange losses, despite strategic divestiture and capital return.
NYSE
Fresenius Medical Care AG announced a significant increase in net income and operating income for 2025, alongside an accelerated share buyback program and strategic portfolio optimization.
NYSE
Jumia Technologies AG reported significantly reduced losses and strong growth in key operational metrics for 2025, driven by strategic exits and enhanced cost efficiency.
NYSE
Woodside Energy Group Ltd reported record annual production in 2025, driven by strong operational performance and strategic project advancements, despite a decrease in net profit after tax.
NYSE
Telefônica Brasil achieved significant revenue growth and expanded its digital ecosystem in 2025, driven by mobile and fiber performance and strategic acquisitions.
NYSE
Triton International Limited reported a decrease in net income attributable to common shareholders for 2025, driven by market challenges including reduced container demand and historically low lease rates, despite strategic acquisitions and debt refinancing.
NASDAQ
ZenaTech, Inc. filed an amended annual report clarifying financial line items and providing updates on recent software and drone business acquisitions, alongside ongoing product development and regulatory efforts.
NYSE
BBVA announced a 4.5% increase in profit attributable to the parent company, reaching €10,511 million in 2025, driven by robust net interest income and strategic digital investments.
NYSE
Ferrari N.V. reported robust financial results for 2025 with increased revenues and profits, driven by a richer product mix and strategic launches, alongside significant advancements in its electrification strategy.
NYSE
Rio Tinto plc and Rio Tinto Limited announced their 2025 fiscal year results, highlighting increased revenue, underlying EBITDA, and net cash generated from operating activities, alongside strategic progress in key growth areas.
OTC.Pink
Rio Tinto reports increased sales revenue and underlying EBITDA in 2025, driven by a diversified portfolio and operational excellence, despite a tragic fatality and geopolitical volatility.
NYSE
RELX PLC delivered robust financial performance in 2025 with underlying revenue growth of 7% and adjusted EPS growth of 10% at constant currency, driven by its shift towards higher-value analytics and AI-enabled decision tools.
NYSE
Royal Philips reported a significant financial turnaround in 2025 with increased comparable sales and expanded margins, despite ongoing Respironics recall litigation and a complex global environment.
NYSE
NatWest Group plc announced robust financial results for 2025, with significant profit growth, increased shareholder distributions, and positive momentum across its core banking segments.
NASDAQ
Sanofi's 2025 annual report highlights robust net sales growth, fueled by Dupixent and strategic acquisitions, despite significant R&D setbacks and ongoing generic competition.
NASDAQ
Genmab reports strong 2025 financial results driven by product sales and royalties, while strategically expanding its late-stage pipeline through the acquisition of Merus N.V. and advancing key proprietary assets.
AMEX
Enigmatig Limited reports increased corporate services income in Fiscal 2025, driven by client expansion and higher-value services, despite a net profit decline due to increased operating expenses related to its IPO and new office leases.